Rebecca Roylance Selected Research

Rebecca Roylance Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 12/2023 - 05/2009
17	Neoplasms (Cancer) 04/2024 - 01/2006
3	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2023 - 02/2016
3	COVID-19 01/2023 - 01/2020
3	Chromosomal Instability (Chromosome Stability) 11/2014 - 02/2012
2	Disease Progression 12/2023 - 01/2023
2	Triple Negative Breast Neoplasms 12/2023 - 01/2018
2	Fatigue 01/2023 - 10/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Vomiting 01/2023
1	Breakthrough Infections 01/2023
1	Alopecia (Baldness) 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Nausea 01/2023
1	Infections 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Myocarditis (Carditis) 01/2021
1	Prediabetic State (Prediabetes) 01/2021
1	Glucose Intolerance 01/2021
1	Exanthema (Rash) 10/2020
1	Bone Resorption 01/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Breast Carcinoma In Situ 01/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2014
1	Polyploidy 02/2012
1	Pathologic Complete Response 05/2009

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2006
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2014
3	Circulating Tumor DNAIBA 01/2022 - 01/2020
3	Hormones (Hormone)IBA 01/2022 - 04/2019
2	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2010
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
2	Estrogen ReceptorsIBA 02/2016 - 10/2011
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023
1	olaparibIBA 12/2023
1	ceralasertibIBA 12/2023
1	Oral ContraceptivesIBA 09/2023
1	BilirubinIBA 01/2023
1	VaccinesIBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	trastuzumab deruxtecanIBA 01/2023
1	SARS-CoV-2 spike proteinIBA 01/2023
1	Ado-Trastuzumab EmtansineIBA 01/2023
1	CreatinineIBA 01/2023
1	CalciumIBA 01/2022
1	Cyclin-Dependent Kinase 4IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Estrogens (Estrogen)FDA Link 05/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	ribociclibIBA 01/2021
1	capivasertibIBA 10/2020
1	neratinibIBA 10/2020
1	Fulvestrant (Faslodex)FDA Link 10/2020
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 10/2020
1	rucaparibIBA 01/2020
1	InterferonsIBA 01/2020
1	palbociclibIBA 04/2019
1	Trinitrotoluene (TNT)IBA 01/2018
1	PlatinumIBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	OsteoprotegerinIBA 01/2017
1	Progesterone FDA LinkGeneric 01/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	NF-kappa B (NF-kB)IBA 01/2017
1	LigandsIBA 01/2017
1	Aurora Kinase AIBA 11/2014
1	SurvivinIBA 11/2014
1	Urea (Carbamide)FDA LinkGeneric 02/2014
1	Folic Acid AntagonistsIBA 02/2014
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 02/2014
1	EnzymesIBA 02/2014
1	Arginine (L-Arginine)FDA Link 02/2014
1	taxaneIBA 06/2013
1	CeramidesIBA 02/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2012
1	Cadherins (E-Cadherin)IBA 06/2006

Therapy/Procedure

11	Therapeutics 04/2024 - 05/2009
7	Drug Therapy (Chemotherapy) 01/2023 - 05/2009
2	Adjuvant Chemotherapy 10/2020 - 02/2012
1	Radiotherapy 01/2021
1	Palliative Care (Palliative Therapy) 05/2009